Merkel pushes back on vaccine patent waiver in row with US2 min read . Updated: 06 May 2021, 10:10 PM IST
- Pharmaceutical stocks that had sunk on the news of the US proposal rebounded on Merkel’s stance
- Moderna Inc. was down 2.1% after falling as low as 12% earlier. CureVac NV fell 5.4%, an improvement from its earlier 13% decline, while BioNTech SE was down 3.5% after earlier dropping 15%
German Chancellor Angela Merkel weighed in against a U.S. proposal to waive patent protections for Covid-19 vaccines, casting doubt on whether the idea has enough international support to become a reality.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more